Article

Going Broke Paying for Cancer Medications? This May Help

Author(s):

How I saved big on costly prescription medications for cancer treatment.

Recently I wrote an article about how job loss for those with critical illnesses can be somewhat more stressful than for those who don’t have ongoing health issues. For me, outside of medical care, one of my biggest expenses is medication.

My recent experience with being in between jobs included a COBRA insurance bill of $1,010 per month — seems legit (no, not really). The costs of medications were covered for the most part, but the COBRA was killing me. My only option was to literally stick it out (no insurance) until my next job, but I had to have an option for my medications.

I reached out to a few government services locally. One told me it would take me four months to actually start receiving any help with my medications. Other services I was referred to didn’t respond to my calls. Luckily, I found Blink Health. I’d briefly mentioned Blink in my last article, but had not used it until recently.

Here’s how Blink works. Simply logon to the site, shop for your medications, add them to your cart and checkout. A Blink card will then be sent to you by email or to your mobile phone. You will need this to pick up your medications at one of the participation pharmacies — and, of course, you will also need your prescriptions.

Personally, I have saved as high as 96 percent on the purchase of some of my medications. This service has truly been a lifesaver for me and I’m sure it can help many others out there who struggle with medical expenses every day. Give it a shot.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Image of woman with brown hair.
Adolescent and Young Adult Cancer Awareness Week sheds light on the financial hardships young cancer survivors face, including debt and limited assistance.
Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for relapsed/refractory large B-cell lymphoma.
Treatment with cemacabtagene ansegedleucel demonstrated responses in patients with relapsed or treatment-resistant large B-cell lymphoma.
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Sattva S. Neelapu, a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma
Image of a smiling woman with brown hair.
Image of a woman with a brown hair tied into a bun.